Mark P. Lappe

Mr. Lappe co-founded Inhibrx in 2010 and has served as Chief Executive Officer since their inception. He also serves as the Chairman of their board of directors. Mr. Lappe has extensive expertise in the biotechnology industry with over 30 years of experience in executive management, investment management, and executive recruiting, having built the executive teams of over 40 start-up biotechnology and medical device companies. Prior to founding Inhibrx, Mr. Lappe was the founder and Managing Partner of Efficacy Biotech Fund, a fund focused on strategic investment in public biotechnology companies.